🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

953 results for “injection” Clear

  1. UTAA91 injection

    Suzhou Ribo Life Science Co.

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial

  2. UTAA91 injection

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis (RA)

    phase 1 mab active

    1 trial

  3. VSA001 injection

    Arrowhead Pharmaceuticals Ireland Limited

    Healthy Adult Volunteers

    phase 1 small molecule completed

    1 trial

  4. Vyxeos 44 MG / 100 MG Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Relapsed Pediatric AML

    phase 1 small molecule active

    1 trial

  5. WGc-0201 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  6. YTS104 Cells injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed or Refractory Multiple Myeloma

    phase 1 mab active

    1 trial

  7. YTS109 cell injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis (LN)

    phase 1 small molecule active

    1 trial

  8. ZB001 for injection

    Zenas BioPharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  9. ZB001 for injection

    Zenas BioPharma

    Thyroid Eye Disease

    phase 1 small molecule completed

    1 trial

  10. ZG0895 Hydrochloride for Injection

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  11. Ziftomenib, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Solu-Cortef Powder for Solution for Injection or Infusion 100 mg

    AXIM BIOTECHNOLOGIES, INC.

    Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Acute Lymphocytic Leukemia

    phase 1 small molecule active

    1 trial

  12. [11C]CPPC Injection

    Chongqing Precision Biotech Co., Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule terminated

    1 trial

  13. dexlansoprazole injection

    The First People's Hospital of Lianyungang

    Safety Issues

    phase 1 small molecule completed

    1 trial

  14. oncolytic virus (OVV-01) injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neoplasms

    phase 1 small molecule active

    1 trial

  15. paclitaxel cationic liposome for injection

    CSPC Baike (Shandong) Biopharmaceutical Co.,

    Colorectal Liver Metastases

    phase 1 small molecule active

    1 trial

  16. recombinant human thrombopoietin injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Liver Disease Chronic

    phase 1 small molecule active

    1 trial

  17. 0.9% Sodium Chloride Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    1 trial

  18. ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection, ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 1 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection

    Swedish Orphan Biovitrum AB (publ)

    Haemophilia A

    approved small molecule active

    1 trial

  19. ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection

    Swedish Orphan Biovitrum AB (publ)

    Haemophilia A

    approved small molecule active

    1 trial

  20. Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

    Pfizer Australia Pty Ltd

    RSV-infection

    approved small molecule active

    1 trial

  21. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  22. Aflibercept Injection

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials

  23. Alcohol injection

    The University of Hong Kong

    Malignancy

    approved small molecule active

    1 trial

  24. Alirocumab 150 MG/ML subcutaneous injection

    Regeneron UK Limited

    Saphenous Vein Graft Atherosclerosis

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources